Latest news and press releases about Health Catalyst, Inc. (HCAT): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into existing business intelligence tools, thereby enhancing analytical precision.
Price
| Price | $1.73 |
| Market Cap | $128M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 1.28 |
| EV / EBITDA | -1.25 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -129.70% |
| Return on Invested Capital | -21.13% |
| Return on Assets | -73.85% |
| Gross Margin | 46.44% |
| Operating Margin | -19.67% |
| Net Margin | -90.61% |
Explore sector: Healthcare · Medical - Healthcare Information Services
More sections of HCAT: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks